​

Arcturus Therapeutics Ownership | Who Owns Arcturus Therapeutics?

OverviewForecastRevenueFinancialsChartTranscripts

Arcturus Therapeutics Ownership Summary

Arcturus Therapeutics is owned by 88.69% institutional investors, 7.99% insiders, and 3.32% retail investors. Federated hermes is the largest institutional shareholder, holding 12.06% of ARCT shares. ARK Genomic Revolution ETF is the top mutual fund, with 9.85% of its assets in Arcturus Therapeutics shares.

ARCT Ownership Benchmark

TypeName% Inst% Insiders% Retail
StockArcturus Therapeutics88.69%7.99%3.32%
SectorHealthcare Stocks 35.56%12.08%52.36%
IndustryBiotech Stocks 35.43%12.01%52.56%

Institutional Shareholders

Top Institutional Shareholders by Total Shares

HolderShares% HoldingValue
Federated hermes3.30M12.06%$25.50M
Ark investment management2.77M10.11%$21.38M
Blackrock funding, inc. /de2.61M9.20%$17.57M
Nikko asset management americas2.29M8.36%$17.65M
Vanguard group2.09M7.69%$12.81M
Sumitomo mitsui trust1.96M6.91%$13.19M
Two sigma investments, lp1.08M3.95%$8.35M
Balyasny asset management864.10K3.19%$11.24M
Geode capital management660.93K2.41%$5.10M
State street569.60K2.00%$3.83M

Top Institutional Shareholders by % of Total Assets

HolderShares% AssetsValue
Nverses capital38.95K0.40%$261.74K
Nikko asset management americas2.29M0.25%$17.65M
Diadema partners lp48.81K0.23%$899.59K
Ark investment management2.77M0.17%$21.38M
Persistent asset partners11.19K0.14%$206.21K
Empire life investments366.22K0.14%$2.46M
Stempoint capital lp35.61K0.13%$656.22K
Green alpha advisors27.09K0.12%$182.05K
Belmont capital40.00K0.11%$678.80K
Hap trading77.14K0.10%$1.42B

Top Buyers

HolderShares% AssetsChange
Two sigma investments, lp1.08M0.01%535.10K
Nikko asset management americas2.29M0.25%262.35K
Ubs group458.28K0.00%230.38K
Vanguard group2.09M0.00%204.04K
Millennium management478.56K0.00%173.78K

Top Sellers

HolderShares% AssetsChange
Arrowstreet capital, limited partnership---552.18K
Bioimpact capital---459.94K
Jane street group23.08K--399.34K
Sumitomo mitsui trust1.96M0.01%-325.81K
Jupiter asset management---319.45K

New Positions

HolderShares% AssetsChangeValue
Vanguard fiduciary trust169.81K0.00%169.81K$1.31M
Hap trading77.14K0.10%77.14K$1.42B
Jump financial68.29K0.01%68.29K$527.22K
Caption management58.46K0.01%58.46K$1.08M
Diadema partners lp48.81K0.23%48.81K$899.59K

Sold Out

HolderChange
Larson financial group-1.00
Capital performance advisors llp-2.00
Frazier financial advisors-4.00
Gps wealth strategies group-10.00
Geowealth management-19.00

Institutional Ownership Trends

DateHoldingsChange %SharesChange %OwnershipChange %Increased PositionChange %Decreased PositionChange %
Mar 31, 2026128-2.29%24,289,0472.49%881.17%7210.77%37-5.13%
Dec 31, 202530-81.60%5,262,265-79.65%190.21%13-83.12%12-70.00%
Sep 30, 202550-65.75%9,612,435-60.70%350.44%21-71.62%13-66.67%
Jun 30, 20251542.67%25,761,135-3.22%940.98%7814.71%42-14.29%
Mar 31, 2025148-5.73%26,589,017-0.21%981.01%67-4.29%494.26%

Top Mutual Funds Shareholders

HolderShares% HoldingChange
ARK Genomic Revolution ETF2.80M9.85%61.13K
ARK Genomic Revolution2.75M9.69%121.28K
Federated Hermes Kaufmann R2.07M7.29%-
Federated Hermes Kaufmann Growth2.07M7.29%-
Amova ARK Pstv Chg Innovt P JPY Acc1.73M6.07%-141.04K
Nikko AM ARK Pstv Chg Innovt P JPY Acc1.61M5.93%-56.86K
Federated Hermes Kaufmann Small Cap Grow1.19M4.18%-
Federated Hermes Kaufmann Small Cap A1.19M4.18%-
Vanguard Morn Total Stk Mkt Idx Investor797.15K2.80%-
Vanguard Total Stock Mkt Idx Inv797.15K2.80%-

Recent Insider Transactions

DateNameRoleActivityValue
Aug 15, 2025SASSINE ANDY Chief Financial OfficerBuy$20.50K
Aug 15, 2025SASSINE ANDY Chief Financial OfficerSell$20.50K
Oct 15, 2024Chivukula Pad Chief Scientific Officer & COOSell$249.12K
Jun 12, 2024SASSINE ANDY Chief Financial OfficerSell$1.60M
Jun 05, 2024Chivukula Pad Chief Scientific Officer & COOSell$5.13K

Insider Transactions Trends

DateBuySell
2025 Q4--
2025 Q32-
2025 Q2--
2024 Q4-1
2024 Q2-3

ARCT Ownership FAQ

Who Owns Arcturus Therapeutics?

Arcturus Therapeutics shareholders are primarily institutional investors at 88.69%, followed by 7.99% insiders and 3.32% retail investors. The average institutional ownership in Arcturus Therapeutics's industry, Biotech Stocks , is 35.43%, which Arcturus Therapeutics exceeds.

Who owns the most shares of Arcturus Therapeutics?

Arcturus Therapeutics’s largest shareholders are Federated hermes (3.3M shares, 12.06%), Ark investment management (2.77M shares, 10.11%), and Blackrock funding, inc. /de (2.61M shares, 9.20%). Together, they hold 31.37% of Arcturus Therapeutics’s total shares outstanding.

Does Blackrock own Arcturus Therapeutics?

BlackRock is not among the top 10 institutional shareholders of Arcturus Therapeutics.

Who is Arcturus Therapeutics’s biggest shareholder by percentage of total assets invested?

Nverses capital is Arcturus Therapeutics’s biggest shareholder by percentage of total assets invested, with 0.40% of its assets in 38.95K Arcturus Therapeutics shares, valued at 261.74K$.

Who is the top mutual fund holder of Arcturus Therapeutics shares?

ARK Genomic Revolution ETF is the top mutual fund holder of Arcturus Therapeutics shares, with 9.85% of its total shares outstanding invested in 2.8M Arcturus Therapeutics shares.

Try Tickergate Pro Free

Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)

  • Customize your own personal stocks lists, views and charts

  • Choose from hundreds of fields, up to 15 years of history

  • Conduct deep comparison analysis

  • Discover trending investment themes

  • Find your next best investment

  • Research stocks using tools